In general, a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection. However, to work with highly contagious pathogens, it is necessary to take precautions against laboratory-acquired infection. We have learned many lessons from the recent outbreak of severe acute respiratory syndrome (SARS). In order to develop an effective vaccine and diagnostic tools, we prepared UV-inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 (BSL3) regulation. Our protocol for large-scale preparation of UV-inactivated SARS-CoV including virus expansion, titration, inactivation, and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future.
Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen
Published 2007 in Methods in molecular biology
ABSTRACT
PUBLICATION RECORD
- Publication year
2007
- Venue
Methods in molecular biology
- Publication date
2007-11-28
- Fields of study
Biology, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-7 of 7 references · Page 1 of 1
CITED BY
Showing 1-35 of 35 citing papers · Page 1 of 1